SeerPharma was asked to provide validation management and execution support for an established Active Pharmaceutical Ingredient (API) production facility in Australia.
After reviewing the market with a project to replace their existing GMP induction and refresher training program, a leading Australian natural health care brand has recognised the value of SeerPharma’s online GMP training solution.
Zuellig Pharma is Asia’s leading healthcare service provider offering a broad range of innovative services including distribution of pharmaceuticals, medical devices, special solutions and other healthcare related consumer products.
As a Pharmaceutical company, you are required to investigate the cause of quality failures or production problems. Surprisingly though, “Failure to thoroughly investigate…” is a common finding from regulatory inspections in the PIC/S, TGA and FDA GMP environment.
SeerPharma has assisted an Australian 3D Printing Medical Device company to develop an ISO 13485 compliant Quality Management System (QMS).
As a Medical Device company, you are required to investigate the cause of quality failures or production problems. Surprisingly though, “Failure to thoroughly investigate…” is a common finding from quality (management) system inspections and audits against FDA 21 CFR Part 820 and ISO 13485.
An Australian pharmaceutical company engaged SeerPharma to prepare them for a TGA and FDA GMP inspection. Their Engineers were relatively inexperienced in dealing with regulatory inspections and the company required them to gain experience quickly in preparation for the FDA’s arrival. SeerPharma were requested to perform a mock audit to help meet...
Linear Clinical Research specialises in the conduct of early phase clinical trials and has a purpose built phase I facility to support first-in-human through to phase II clinical trials.
A multinational pharmaceutical company has been using SeerPharma’s online GMP training solution "E-learning" for new employee and refresher training since October 2012. With additional staff coming on board, SeerPharma has altered the implementation model to provide the client with more functionality as well as the independence to self-manage the...
A US-based biopharmaceutical firm has approached SeerPharma to perform audits of their critical service providers. The company is about to undertake a phase I clinical trial in Australia of one of its therapeutic molecules.
